These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17262970)

  • 1. [The application of siRNA in therapeutics].
    Mei L; Li XJ
    Sheng Li Ke Xue Jin Zhan; 2006 Oct; 37(4):347-52. PubMed ID: 17262970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA therapeutics: big potential from small RNAs.
    Ryther RC; Flynt AS; Phillips JA; Patton JG
    Gene Ther; 2005 Jan; 12(1):5-11. PubMed ID: 15496962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA interference: potential therapeutic targets.
    Jana S; Chakraborty C; Nandi S; Deb JK
    Appl Microbiol Biotechnol; 2004 Nov; 65(6):649-57. PubMed ID: 15372214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.
    DeVincenzo JP
    Antivir Ther; 2012; 17(1 Pt B):213-25. PubMed ID: 22311654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference and potential therapeutic applications of short interfering RNAs.
    Karagiannis TC; El-Osta A
    Cancer Gene Ther; 2005 Oct; 12(10):787-95. PubMed ID: 15891770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic application of RNA interference for hepatitis C virus.
    Watanabe T; Umehara T; Kohara M
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1263-76. PubMed ID: 17822803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA--getting the message out.
    Lee SH; Sinko PJ
    Eur J Pharm Sci; 2006 Apr; 27(5):401-10. PubMed ID: 16442784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference (RNAi) in hematology.
    Scherr M; Steinmann D; Eder M
    Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of chronic hepatitis B virus infection: a promising approach using small interfering RNA (siRNA).
    Dwivedi M; Misra SP; Misra V; Waikhom RK; Bhatnagar M
    Natl Med J India; 2008; 21(3):123-7. PubMed ID: 19004143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promise and challenge of RNA interference-based therapy for cancer.
    Petrocca F; Lieberman J
    J Clin Oncol; 2011 Feb; 29(6):747-54. PubMed ID: 21079135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [RNA interference and molecular pathology of selected diseases].
    Lochmanová J; Bartos M
    Cas Lek Cesk; 2008; 147(12):607-15. PubMed ID: 19235485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.
    Meade BR; Dowdy SF
    Discov Med; 2009 Dec; 8(43):253-6. PubMed ID: 20040280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [RNA interference (RNAi) and its therapeutic potential in cancer].
    Vázquez-Vega S; Contreras-Paredes A; Lizano-Soberón M; Amador-Molina A; García-Carrancá A; Sánchez-Suárez LP; Benítez-Bribiesca L
    Rev Invest Clin; 2010; 62(1):81-90. PubMed ID: 20415062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing or stimulation? siRNA delivery and the immune system.
    Whitehead KA; Dahlman JE; Langer RS; Anderson DG
    Annu Rev Chem Biomol Eng; 2011; 2():77-96. PubMed ID: 22432611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi therapeutics: an update on delivery.
    Nguyen T; Menocal EM; Harborth J; Fruehauf JH
    Curr Opin Mol Ther; 2008 Apr; 10(2):158-67. PubMed ID: 18386228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of RNA interference to minimize ischemia reperfusion injury.
    Zhang ZX; Min WP; Jevnikar AM
    Transplant Rev (Orlando); 2012 Apr; 26(2):140-55. PubMed ID: 22000663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring in vitro roles of siRNA in cardiovascular disease.
    Tang Y; Ge YZ; Yin JQ
    Acta Pharmacol Sin; 2007 Jan; 28(1):1-9. PubMed ID: 17184576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.